Re: ZHCLF up 290% to $0.16...question

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: ZHCLF up 290% to $0.16...question

in response to

Re: ZHCLF up 290% to $0.16...question

RVXoldtimer

posted on Dec 14, 2020 05:50PM

RVXOT, we're left with a conundrum seeing that "ZHCLF" is trading on the OTC according to josh4580.

So if it's not ZCC (Calgary, & I agree with that notion because Zenith, Calgary said so), who could it be. Does it mean that FIRNA assigned "ZHCLF" to another company trading on the OTC - and it so happens that it has the same number of outstanding shares as ZCC, Calgary?